1 |
Insogna KL. Primary Hyperparathyroidism. N Engl J Med 2018;379:1050-1059.
DOI
|
2 |
Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med 2011;365:2389-2397.
DOI
|
3 |
Cogan MG, Covey CM, Arieff AI, Wisniewski A, Clark OH, Lazarowitz V, et al. Central nervous system manifestations of hyperparathyroidism. Am J Med 1978;65:963-970.
DOI
|
4 |
Turken SA, Cafferty M, Silverberg SJ, De La Cruz L, Cimino C, Lange DJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 1989;87:553-557.
DOI
|
5 |
Logullo F, Babbini MT, Di Bella P, Provinciali L. Reversible combined cognitive impairment and severe polyneuropathy resulting from primary hyperparathyroidism. Ital J Neurol Sci 1998;19:86-89.
DOI
|
6 |
Gentric A, Jezequel J, Pennec YL. Severe neuropathy related to primary hyperparathyroidism cured by parathyroidectomy. J Am Geriatr Soc 1993;41:759.
DOI
|
7 |
Delbridge LW, Marshman D, Reeve TS, Crummer P, Posen S. Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery. Med J Aust 1988;149:74-76.
DOI
|
8 |
Diniz ET, Bandeira F, Lins OG, Cavalcanti EN, de Arruda TM, Januario AM, et al. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr Pract 2013;19:219-225.
DOI
|
9 |
Schlaepfer WW, Bunge RP. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol 1973;59(2 Pt 1):456-470.
DOI
|